NfL was found to be the most reliable biomarker for CBS-Aβ(–), reflecting its role as a marker of axonal damage and brain atrophy in neurodegenerative diseases, underlining its usefulness in identifying non-amyloid pathologies. Here, CBS is linked to Brain atrophy.